Ginkgo Bioworks Holdings (DNA) Change in Cash (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Change in Cash for 7 consecutive years, with -$16.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash rose 83.99% year-over-year to -$16.7 million; the trailing twelve-month figure through Jun 2026 stood at -$79.3 million (up 84.87% YoY), and the FY2025 full-year result was -$393.4 million, down 2.48% from the prior year.
• Change in Cash rose to -$16.7 million in Q2 2026 per DNA's latest filing, from -$23.7 million in the prior quarter.
• Across five years, Change in Cash topped out at $55.4 million in Q4 2025 and bottomed at -$250.3 million in Q1 2025.
• Historically, Change in Cash has averaged -$78.9 million across 5 years, with a median of -$90.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 536.35% in 2023, then soared 199.31% in 2025.
• Over 5 years, Change in Cash stood at $24.1 million in 2022, then sank by 536.35% to -$105.0 million in 2023, then jumped by 46.88% to -$55.8 million in 2024, then jumped by 199.31% to $55.4 million in 2025, then slumped by 130.06% to -$16.7 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$16.7 million, -$23.7 million, and $55.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.